Back to Search
Start Over
[Cost Effectiveness of Treatments of Psoriasis with a PASI 75 and one Period of 12 Weeks].
- Source :
-
Revista espanola de salud publica [Rev Esp Salud Publica] 2016 Apr 13; Vol. 90, pp. E15. Date of Electronic Publication: 2016 Apr 13. - Publication Year :
- 2016
-
Abstract
- Objective: The objective was to evaluate the efficiency (relation between the cost and the results in health) of the treatments in psoriasis, seeking a higher quality of economic evaluations, consistency and transparency in these studies.<br />Methods: We developed a model of economic evaluation in psoriasis collecting all the many direct and indirect costs of each treatment. The effectiveness indicator used was Psoriasis Area Severity Index [PASI 75] which is generally acceptable in studies of psoriasis. The effectiveness indicator was a PASI 75.Subsequently we calculated the Incremental Cost-Effectiveness Ratio (ICER) for the period of 12 weeks and PASI 75, ordering treatments by level of effectiveness at the expense of treatment costs.<br />Results: The most cost effective treatment was methotrexate (ICER -7.5) followed by acitretin (ICER 29.5). The least cost has proved effective PUVA (ICER 4,651), followed by UVB narrow band (2,886.1).<br />Conclusions: when taking into account both direct and indirect costs together with efficiency, methotrexate is the most cost effective treatment.
- Subjects :
- Acitretin economics
Acitretin therapeutic use
Adalimumab economics
Adalimumab therapeutic use
Cyclosporine economics
Cyclosporine therapeutic use
Etanercept economics
Etanercept therapeutic use
Health Care Costs
Humans
Immunosuppressive Agents economics
Immunosuppressive Agents therapeutic use
Infliximab economics
Infliximab therapeutic use
Methotrexate economics
Methotrexate therapeutic use
Models, Economic
PUVA Therapy economics
Severity of Illness Index
Spain
Time Factors
Treatment Outcome
Ultraviolet Therapy economics
Ustekinumab economics
Ustekinumab therapeutic use
Cost-Benefit Analysis
Psoriasis drug therapy
Subjects
Details
- Language :
- Spanish; Castilian
- ISSN :
- 2173-9110
- Volume :
- 90
- Database :
- MEDLINE
- Journal :
- Revista espanola de salud publica
- Publication Type :
- Academic Journal
- Accession number :
- 27073006